|
98
|
265
|
6p9fA |
Crystal structure of rar-related orphan receptor c (nhis-rorgt(244-487)-l6-src1(678-692)) in complex with a phenyl (3-phenylpyrrolidin-3-yl)sulfone inhibitor |
|
160
|
519
|
6pffA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-cyanobenzoic acid. |
|
152
|
519
|
6pf9A |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)phenyl)acetic acid. |
|
161
|
519
|
6pfdA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)terephthalic acid. |
|
164
|
519
|
6pfhA |
Crystal structure of ts-dhfr from cryptosporidium hominis in complex with nadph, fdump and 2-(2-(4-((2-amino-4-oxo-4,7-dihydro-3h-pyrrolo[2,3-d]pyrimidin-5-yl)methyl)benzamido)-4-cyanophenyl)acetic acid. |
|
83
|
281
|
6op9A |
Her3 pseudokinase domain bound to bosutinib |
|
94
|
271
|
6omuA |
Structure of human bruton's tyrosine kinase in complex with evobrutinib |
|
65
|
247
|
6nrfA |
Crystal structure of human parp-1 art domain bound to inhibitor utt103 |
|
66
|
247
|
6nriA |
Crystal structure of human parp-1 art domain bound to inhibitor utt83 |
|
66
|
247
|
6nrjA |
Crystal structure of human parp-1 art domain bound to inhibitor utt93 |
|
69
|
247
|
6nrhA |
Crystal structure of human parp-1 art domain bound inhibitor utt63 |
|
68
|
247
|
6nrgA |
Crystal structure of human parp-1 art domain bound to inhibitor utt57 |
|
103
|
342
|
6mynA |
Crystal structure of murine nf-kappab inducing kinase (nik) bound to inhibitor r7 |
|
115
|
347
|
6nbsA |
Wt erk2 with compound 2507-8 |
|
99
|
306
|
6mobA |
Crystal structure of kit1 in complex with dp2976 via co-crystallization |
|
102
|
321
|
6ig8A |
Crystal structure of csf-1r kinase domain with a small molecular inhibitor, jte-952 |
|
73
|
276
|
6e6eA |
Dgy-06-116, a novel and selective covalent inhibitor of src kinase |
|
77
|
296
|
6n3lA |
Identification of novel, potent and selective gcn2 inhibitors as first-in-class anti-tumor agents |
|
69
|
297
|
6n3nA |
Identification of novel, potent and selective gcn2 inhibitors as first-in-class anti-tumor agents |
|
80
|
298
|
6n3oA |
Identification of novel, potent and selective gcn2 inhibitors as first-in-class anti-tumor agents |
|
66
|
288
|
6mepA |
Crystal structure of the catalytic domain of the proto-oncogene tyrosine-protein kinase mer in complex with inhibitor unc3437 |
|
107
|
400
|
6p3uA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt335 |
|
109
|
400
|
6p3tA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt449 |
|
80
|
273
|
6n0pA |
Braf in complex with n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide (lxh254) |
|
109
|
400
|
6p3vA |
Crystal structure of eis from mycobacterium tuberculosis in complex with inhibitor sgt416 |
|
291
|
1016
|
6pyrA |
Human pi3kdelta in complex with compound 2-10 ((3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one) |
|
307
|
1018
|
6pyuA |
Human pi3kdelta in complex with compound 4-2 ((3s)-1'-(cyclopropanecarbonyl)-5-(quinoxalin-6-yl)spiro[indole-3,2'-pyrrolidin]-2(1h)-one) |
|
294
|
945
|
6pysA |
Human pi3kalpha in complex with compound 2-10 ((3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one) |
|
80
|
169
|
6pyrB |
Human pi3kdelta in complex with compound 2-10 ((3s)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2h-indol-2-one) |
|
111
|
338
|
6pk6A |
Human prpf4b bound to benzothiophene inhibitor 329 |
|
116
|
332
|
6pjjA |
Human prpf4b bound to benzothiophene inhibitor 224 |
|
79
|
168
|
6pyuB |
Human pi3kdelta in complex with compound 4-2 ((3s)-1'-(cyclopropanecarbonyl)-5-(quinoxalin-6-yl)spiro[indole-3,2'-pyrrolidin]-2(1h)-one) |
|
0
|
8
|
6pdoB |
Human pim1 bound to benzothiophene inhibitor 354 |
|
81
|
274
|
6pdnA |
Human pim1 bound to benzothiophene inhibitor 292 |
|
88
|
270
|
6pdpA |
Human pim1 bound to benzothiophene inhibitor 379 |
|
82
|
271
|
6pdoA |
Human pim1 bound to benzothiophene inhibitor 354 |
|
92
|
239
|
6pnmA |
Human gsto1-1 complexed with 2-chloro-n-(4-chloro-3-(morpholinosulfonyl)phenyl)acetamide |
|
93
|
238
|
6pnnA |
Human gsto1-1 complexed with 2-chloro-n-(4-chloro-3-(n-(2-methoxyethyl)-n-methylsulfamoyl)phenyl)acetamide |
|
91
|
239
|
6pnoA |
Human gsto1-1 complexed with 2-chloro-n-(4-chloro-3-(n-isopropylsulfamoyl)phenyl)acetamide |
|
80
|
274
|
6pcwA |
Human pim1 bound to benzothiophene inhibitor 213 |
|
84
|
274
|
6pdiA |
Human pim1 bound to benzothiophene inhibitor 224 |
|
0
|
8
|
6pdnB |
Human pim1 bound to benzothiophene inhibitor 292 |
|
88
|
289
|
6nvhA |
Fgfr4 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide |
|
85
|
289
|
6nviA |
Fgfr4 complex with n-(3-chloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-5-fluorophenyl)acrylamide |
|
181
|
458
|
6e0iA |
Crystal structure of glucokinase in complex with compound 72 |
|
161
|
448
|
6e0eA |
Crystal structure of glucokinase in complex with compound 6 |
|
83
|
303
|
6nvlA |
Fgfr1 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-methylphenyl)acrylamide |
|
86
|
290
|
6nvjA |
Fgfr4 complex with n-(2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)-3-fluorophenyl)acrylamide |
|
85
|
290
|
6nvgA |
Fgfr4 complex with n-(3,5-dichloro-2-((5-((2,6-dichloro-3,5-dimethoxybenzyl)oxy)pyrimidin-2-yl)amino)phenyl)acrylamide |
|
81
|
289
|
6nvkA |
Fgfr4 complex with blu-554, n-((3s,4s)-3-((6-(2,6-dichloro-3,5-dimethoxyphenyl)quinazolin-2-yl)amino)tetrahydro-2h-pyran-4-yl)acrylamide |
